Name
Purdue University Globle
NU576 NP II – Primary Care of Women’s Health
Prof. Name
Date
During the second trimester of pregnancy, prenatal care focuses on monitoring maternal and fetal well-being, identifying potential complications, completing recommended screening tests, and supporting the mother’s physical and emotional health. For a 35-year-old patient at 20 weeks’ gestation, routine prenatal care should also address pregnancy-related back pain, alcohol exposure, previous pregnancy losses, advanced maternal age, and a history of depression. In this case, continued prenatal monitoring, mental health screening, substance-use counseling, and appropriate laboratory and diagnostic testing are important components of comprehensive care.
Lara Taylor is a 35-year-old pregnant woman at 20 weeks’ gestation who presents to establish prenatal care after moving from Ohio. She reports mild lower back pain but has no other significant acute complaints. Her symptoms are consistent with common physiological changes during the second trimester. However, her age, obstetric history, history of pregnancy-associated depression, and continued alcohol consumption require additional assessment and patient education.
Patient Name: Lara Taylor
Encounter Number: 5466525
Date of Visit: October 10, 2023
Age: 35 years
Sex: Female
Gestational Age: 20 weeks
The patient presented to establish prenatal care after relocating and stated, “I’m here to establish prenatal care. I just moved here from Ohio.”
Lara Taylor is a 35-year-old gravida 3 patient at 20 weeks’ gestation who recently moved from Ohio and is establishing care with a new prenatal provider. Her primary concern is mild lower back pain described as a “tugging” sensation. The discomfort becomes worse after prolonged standing and improves with rest.
Pregnancy-related lower back pain is common because hormonal changes, increasing uterine size, changes in posture, and additional weight can place greater stress on the lumbar and pelvic structures. Her current presentation does not indicate an acute complication, although her symptoms should continue to be monitored during prenatal visits.
The patient’s obstetric history includes one previous abortion and one miscarriage. She is currently pregnant for the third time. She takes an over-the-counter prenatal vitamin and reports that she discontinued Lexapro several years ago following previous episodes of pregnancy-related depression.
The patient reports an allergy to latex that causes a rash.
The patient reports two previous episodes of depression associated with pregnancy. She denies chronic medical conditions and has no reported history of major trauma.
The patient underwent a dilation and curettage (D&C) procedure approximately five years ago.
The patient’s family history includes cardiovascular and metabolic risk factors. Her father died at age 60 from a myocardial infarction, while her mother has lived with type 2 diabetes mellitus for approximately 10 years. Her brother has no known significant medical concerns.
Lara has a university degree and teaching certification and currently works as a substitute teacher. She married three months ago and lives with her husband, who is currently unemployed following their relocation.
She previously smoked approximately one pack of cigarettes per day but stopped after learning she was pregnant. She denies current illicit drug use but reports a history of marijuana and hemp gummy use.
The most significant current social-health concern is her report of drinking one glass of wine every night during pregnancy. Alcohol crosses the placenta and prenatal alcohol exposure can negatively affect fetal development. Because no amount or type of alcohol has been established as safe during pregnancy, counseling should emphasize complete avoidance of alcohol throughout pregnancy.
The patient reports increased fatigue and weight gain from 155 pounds to 167 pounds.
She denies chest pain and palpitations.
She denies cough, congestion, and shortness of breath.
The patient denies nausea, vomiting, diarrhea, and abdominal pain. She reports constipation that began during pregnancy.
She reports increased urinary frequency, which can occur during pregnancy. She is sexually active with her husband and denies dysuria or other urinary discomfort.
The patient reports mild lower back pain that becomes more noticeable after prolonged standing and improves with rest.
She reports increased breast size but denies breast pain, nipple discharge, or breast masses.
The patient denies weakness, dizziness, and seizures.
The patient’s history of pregnancy-associated depression is clinically important. During the encounter, she avoided eye contact and appeared uncomfortable when discussing her husband. These observations do not establish a psychiatric diagnosis but support the need for additional assessment of her mood, emotional well-being, social support, and potential psychosocial stressors.
The patient’s recorded vital signs are:
Weight: 167 pounds
Height: 5 feet 2 inches
BMI: 30.5 kg/m²
Temperature: 98°F
Blood Pressure: 132/64 mmHg
Pulse: 75 beats/minute
Respiratory Rate: 20 breaths/minute
The patient appears healthy, cooperative, and appropriately responsive during the examination.
The head is normocephalic and atraumatic. Pupils are equal, round, and reactive to light and accommodation. The ear canals and nares are patent, and the teeth are intact without obvious dental caries.
Cardiac examination reveals a regular rate and rhythm with normal S1 and S2 heart sounds. No murmurs or peripheral edema are noted.
Breath sounds are clear bilaterally. Chest expansion is symmetrical, and respirations are unlabored.
The abdomen is gravid with active bowel sounds in all four quadrants. No abdominal tenderness is noted.
The pelvic examination demonstrates a normal vulva without lesions or masses. The vaginal canal appears normal, and the cervix has no lesions or abnormal discharge. The uterus is anteverted and nontender. No hemorrhoids are identified.
The patient has full range of motion in all extremities without significant tenderness or stiffness.
Speech is clear, gait is steady, and posture is appropriate.
The patient is alert and oriented to person, place, and time. Her speech and behavior are appropriate. However, her previous history of pregnancy-associated depression and observed discomfort during portions of the interview warrant continued mental health assessment.
Prenatal testing should be individualized according to the patient’s medical history, previous records, gestational age, and current clinical findings. At 20 weeks, important evaluations may include a complete blood count, infectious disease screening, glucose screening at the recommended gestational age, and fetal ultrasound.
Recommended or potentially indicated testing includes:
Complete blood count (CBC)
Blood type and Rh factor
HIV screening
Syphilis screening
Hepatitis B screening
Gestational diabetes screening at the recommended time
Fetal anatomy ultrasound
Additional testing based on previous prenatal records and individual risk factors
The anatomy ultrasound is particularly relevant around this stage of pregnancy because it can evaluate fetal development and identify certain structural abnormalities.
At 20 weeks’ gestation, the patient is in the second trimester. Her fatigue, weight gain, urinary frequency, breast enlargement, constipation, and mild lower back discomfort can occur as part of normal pregnancy-related physiological changes.
Her lower back pain is most likely associated with musculoskeletal and postural changes related to pregnancy. Nevertheless, prenatal providers should assess pain severity and monitor for symptoms that could suggest another condition.
Although the pregnancy appears generally stable, several factors require additional attention:
Maternal age of 35 years
Previous abortion and miscarriage
History of pregnancy-associated depression
Current alcohol consumption
Previous tobacco use
BMI of approximately 30.5 kg/m²
Recent relocation and changes in social circumstances
Miscarriage refers to pregnancy loss before fetal viability and may present with vaginal bleeding, abdominal or pelvic cramping, or passage of pregnancy tissue. Although this patient has a history of miscarriage, her current presentation does not include symptoms that suggest an active pregnancy loss.
Any new vaginal bleeding, significant pelvic pain, cramping, or passage of tissue should prompt immediate clinical evaluation.
A molar pregnancy is an abnormal gestational condition involving atypical growth of placental tissue. Clinical manifestations can include vaginal bleeding, uterine enlargement that is inconsistent with gestational age, and unusually high human chorionic gonadotropin levels.
The patient’s current history and examination do not provide evidence supporting a molar pregnancy. Diagnostic evaluation should nevertheless be guided by clinical findings and prenatal imaging when indicated.
Medication use during pregnancy should be individualized and discussed with the prenatal care provider. Treatment decisions should consider gestational age, maternal symptoms, potential fetal risks, and safer alternatives.
Depending on the clinical situation, medications that may be considered by the treating provider include acetaminophen for appropriate pain management, docusate for constipation when indicated, and famotidine for reflux symptoms when clinically appropriate.
Patients should not begin, stop, or change medications during pregnancy without consulting their healthcare provider.
Because the patient’s back pain appears mild and related to pregnancy-related musculoskeletal changes, conservative interventions may help improve comfort.
Recommended strategies include:
Avoiding prolonged periods of standing.
Using proper body mechanics when lifting or changing positions.
Taking regular rest breaks.
Performing pregnancy-appropriate stretching and physical activity.
Maintaining comfortable and supportive footwear.
Using appropriate positioning and support while resting.
Persistent, severe, or worsening back pain should be evaluated to exclude other causes.
Patient education is an essential component of prenatal care. Lara should be encouraged to continue attending scheduled prenatal appointments and taking her prenatal vitamin as directed.
Alcohol counseling should be a priority. The patient should be advised to stop consuming alcohol during pregnancy because prenatal alcohol exposure can affect fetal growth and neurodevelopment and may contribute to fetal alcohol spectrum disorders.
Education should also include recognition of symptoms that require prompt medical evaluation, such as:
Vaginal bleeding
Severe or persistent abdominal or pelvic pain
Severe headache
Vision changes
Leakage of fluid
Fever or signs of infection
Contractions or significant cramping
Later in pregnancy, noticeable changes or decreases in fetal movement
The patient’s history of depression during previous pregnancies makes mental health assessment an important part of her prenatal care. Depression and other perinatal mental health conditions can affect maternal functioning, quality of life, prenatal care participation, and pregnancy outcomes.
Screening should be incorporated into prenatal care using a validated tool such as the Edinburgh Postnatal Depression Scale (EPDS) or another appropriate depression screening instrument.
The provider should also ask about:
Current mood and depressive symptoms
Anxiety
Sleep and appetite changes
Social support
Relationship stress
Safety at home
Previous psychiatric treatment
Thoughts of self-harm or suicide
If screening identifies significant symptoms, timely referral for behavioral health evaluation and treatment is appropriate.
Health promotion for this patient should address both routine prenatal needs and her individual risk factors. Continued prenatal care provides an opportunity to monitor maternal weight, blood pressure, fetal development, mental health, nutrition, and substance exposure.
Important preventive measures include:
Maintaining routine prenatal appointments
Taking prenatal vitamins as directed
Following recommended nutrition and physical activity guidance
Completing recommended laboratory and ultrasound testing
Completing gestational diabetes screening at the appropriate time
Avoiding alcohol and illicit substances
Remaining tobacco-free
Monitoring mental health throughout pregnancy
Maintaining appropriate social and emotional support
Continued care with an obstetric provider or OB/GYN is recommended to coordinate prenatal management through the remainder of the pregnancy. Depending on screening results and individual needs, additional referrals may be appropriate.
For example, behavioral health services may be indicated if depression screening is positive. A social worker or other community resource may also be helpful if financial, housing, relationship, employment, or transportation concerns affect the patient’s ability to access prenatal care.
Routine prenatal follow-up should occur according to the patient’s gestational age and the provider’s recommended schedule. The patient should return sooner if she develops concerning symptoms such as vaginal bleeding, severe abdominal or pelvic pain, persistent severe headache, vision changes, leakage of fluid, or other acute concerns.
At subsequent visits, the healthcare team should reassess maternal and fetal well-being, review laboratory and ultrasound results, monitor mental health, reinforce alcohol avoidance, and address any new pregnancy-related symptoms.
Lara Taylor’s presentation is generally consistent with a stable second-trimester pregnancy at 20 weeks’ gestation. Her mild lower back pain, fatigue, constipation, urinary frequency, breast enlargement, and weight gain can occur as part of normal pregnancy-related changes. However, her age, previous pregnancy losses, history of pregnancy-associated depression, and current alcohol use make individualized prenatal counseling particularly important.
Comprehensive care should include appropriate prenatal screening, fetal assessment, mental health screening, alcohol cessation counseling, symptom management, and continued monitoring throughout pregnancy. Early identification of physical or psychological concerns can support maternal well-being and contribute to healthier pregnancy outcomes.
American College of Obstetricians and Gynecologists. (2023). Alcohol and women. https://www.acog.org/womens-health/faqs/alcohol-and-women
American College of Obstetricians and Gynecologists. (2023). Routine tests during pregnancy. https://www.acog.org/womens-health/faqs/routine-tests-during-pregnancy
American College of Obstetricians and Gynecologists. (2023). Depression during pregnancy. https://www.acog.org/womens-health/faqs/depression-during-pregnancy
Centers for Disease Control and Prevention. (2024). About alcohol use during pregnancy. https://www.cdc.gov/alcohol-pregnancy/about/index.html
Johns Hopkins Medicine. (2021). The second trimester. https://www.hopkinsmedicine.org/health/wellness-and-prevention/the-second-trimester
National Institute of Mental Health. (2024). Perinatal depression. https://www.nimh.nih.gov/health/publications/perinatal-depression
World Health Organization. (2023). WHO recommendations on antenatal care for a positive pregnancy experience. https://www.who.int/publications/i/item/9789241549912
